These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18947042)

  • 21. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship.
    Pope CA; Burnett RT; Krewski D; Jerrett M; Shi Y; Calle EE; Thun MJ
    Circulation; 2009 Sep; 120(11):941-8. PubMed ID: 19720932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior predictive ability for death of a basic metabolic profile risk score.
    May HT; Horne BD; Ronnow BS; Renlund DG; Muhlestein JB; Lappé DL; Pearson RR; Carlquist JF; Kfoury AG; Bair TL; Rasmusson KD; Anderson JL
    Am Heart J; 2009 May; 157(5):946-54. PubMed ID: 19376326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative cardiovascular assessment in noncardiac surgery: an update.
    De Hert SG
    Eur J Anaesthesiol; 2009 Jun; 26(6):449-57. PubMed ID: 19359992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Smoking and other risk factors of cardiovascular diseases, connected with arteriosclerosis among youth].
    Chmiel-Połeć Z; Cybulska I
    Przegl Lek; 2008; 65(10):437-45. PubMed ID: 19189518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 28. Model-based benefit-risk assessment: can Archimedes help?
    Krishna R
    Clin Pharmacol Ther; 2009 Mar; 85(3):239-40. PubMed ID: 19223878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modern fairy tale.
    Ferrari R; Guardigli G; Tavazzi L
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S65-7. PubMed ID: 19675442
    [No Abstract]   [Full Text] [Related]  

  • 30. NICE public health guidance: what's new?
    Killoran A; Crombie H; Younger T; Fischer A; White P
    J Public Health (Oxf); 2008 Sep; 30(3):340-1. PubMed ID: 18593726
    [No Abstract]   [Full Text] [Related]  

  • 31. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ; Tangchitnob EP; Lepor NE
    Rev Cardiovasc Med; 2009; 10(2):83-90. PubMed ID: 19593320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving outcomes in high-risk populations using REACH: an inpatient cardiac risk reduction program.
    Patel PV; Gilski D; Morrison J
    Crit Pathw Cardiol; 2009 Sep; 8(3):112-8. PubMed ID: 19726930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative risk reduction in vascular surgery via cardio-protective medication].
    Feringa HH; Bax JJ; Poldermans D
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2606-11. PubMed ID: 19102435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of particulate matter (PM(10), PM(2.5) and PM(1)) on the cardiovascular system.
    Polichetti G; Cocco S; Spinali A; Trimarco V; Nunziata A
    Toxicology; 2009 Jun; 261(1-2):1-8. PubMed ID: 19379789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
    Pierson CA; Epstein BJ; Roberts ME
    J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336
    [No Abstract]   [Full Text] [Related]  

  • 37. Consistent risk factor monitoring systems underpins good public health practice.
    Bull FC; Bauman AE
    Prev Med; 2008 Aug; 47(2):154-5. PubMed ID: 18554707
    [No Abstract]   [Full Text] [Related]  

  • 38. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for safe sports participation: do for yourself what you tell your patients.
    Heidbuchel H
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S14-6. PubMed ID: 19675429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.